Danaher boosted the upper end of its full-year earnings guidance, following a first-quarter beat fueled by double-digit ...

The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger ...

On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

John Crowley, Biotechnology Innovation Organization (BIO) president and CEO, joins 'Squawk Box' to discuss 50 years of ...

Alabama A&M University students made a strong showing at a statewide biotechnology symposium, bringing home top honors at the ...

At the center of AV Laboratories’ innovation is its patented AVL SOM3® complex, a scientifically engineered formulation ...

Do you want to be at the forefront of the rapidly growing biotechnology field? Do you want to develop products derived from living organisms and biomolecules? Do you have a passion for biochemistry, ...

EU Biotech Act I simplifies trials, boosts biomanufacturing, and aims for €10B investment to strengthen Europe's health ...

Missouri S&T’s proposed biochemistry program would combine lab research, data analysis and life sciences to meet growing ...

Vir Biotechnology, Inc. (NASDAQ:VIR) is one of the must-buy small cap stocks to buy. On April 13, Vir Biotechnology, Inc.

Biotechnology advances offer immense public health and consumer potential, but come with serious risks. A recent workshop held by the Council on Foreign Relations brought experts together to discuss ...